https://www.selleckchem.com/pr....oducts/Fluvastatin-S
Background Medical-refractory severe alcoholic hepatitis (AH) has a high mortality. The national frequency, longer-term outcomes and regional practices of AH liver transplantation (LT) in the US are not well described, despite the increasing mortality from alcohol-associated liver disease. Methods We analyzed the trends in frequency and outcomes of UNOS data on 39,455 adult patients who underwent LT from 2014-2019, including AH LT recipients. Results LTs for AH increased 5-fold, from 28 in 2014 to 138 in 2019, varying